Cargando…
In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus
The high level of inherent drug resistance of Mycobacterium abscessus makes the infection caused by it very difficult to be treated. The objective of this study was to evaluate the potential of nosiheptide (NOS) as a new drug candidate for treating M. abscessus infections. The microplate AlamarBlue...
Autores principales: | Zhu, Rui, Yu, Xia, Zhang, Tingting, Kong, Yaoyao, Wang, Fen, Jia, Junnan, Xue, Yi, Huang, Hairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360784/ https://www.ncbi.nlm.nih.gov/pubmed/35958142 http://dx.doi.org/10.3389/fmicb.2022.926361 |
Ejemplares similares
-
Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis
por: Yu, Xia, et al.
Publicado: (2022) -
Lsr2 Is an Important Determinant of Intracellular Growth and Virulence in Mycobacterium abscessus
por: Le Moigne, Vincent, et al.
Publicado: (2019) -
Considerations for Phage Therapy Against Mycobacterium abscessus
por: Senhaji-Kacha, Abrar, et al.
Publicado: (2021) -
Corrigendum: Considerations for Phage Therapy Against Mycobacterium abscessus
por: Senhaji-Kacha, Abrar, et al.
Publicado: (2021) -
Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
por: Tang, Ying Wei, et al.
Publicado: (2018)